Venoarterial extracorporeal membrane oxygenation for patients in shock or cardiac arrest secondary to cardiotoxicant poisoning: A cost-effectiveness analysis

Journal of Critical Care

Volumn 30, Issue 2, 2015, Pages 437.e7-437.e14

  St Onge, Maude ^a,b,g   Fan, Eddy ^a,c,g   Mégarbane, Bruno ^d   Hancock Howard, Rebecca ^e,f   Coyte, Peter C ^a,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b Ontario Poison Centre   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UMR S 1144   (France)

^e ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g Ontario Ministry of Health and Long Term Care ^*  (Canada)

Author keywords

Cardiotoxins; Cost analysis; Extracorporeal circulation; Extracorporeal membrane oxygenation; Overdose; Poisoning

Indexed keywords

ADULT; ARTICLE; CARDIOTOXICITY; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DECISION SUPPORT SYSTEM; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXTRACORPOREAL OXYGENATION; FEMALE; HEALTH CARE COST; HEART ARREST; HUMAN; INTERVENTION STUDY; INTOXICATION; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; OBSERVATIONAL STUDY; PROBABILITY; SENSITIVITY ANALYSIS; SHOCK; SURVIVAL PREDICTION; SURVIVAL RATE; VENOARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION; AGED; CANADA; CHEMICALLY INDUCED; COST BENEFIT ANALYSIS; ECONOMICS; MIDDLE AGED; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

CARDIOTOXIN;

ADULT; AGED; CANADA; CARDIOTOXINS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEALTH CARE COSTS; HEART ARREST; HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84923064455     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.10.010     Document Type: Article

References (35)

1. Bronstein A.C., Spyker D.A., Cantilena L.R., Green J.L., Rumack B.H., Dart R.C. 2011 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report. Clin Toxicol 2012, 50:911-1164.
2. Extracorporeal Life Support Organization Extracorporeal Life Support Organization (ELSO) General Guidelines for all ECLS cases, Version 1.3 2013, 4.
3. St-Onge M., Dubé P.A., Gosselin S., Guimont C., Godwin J., Archambault P.M., et al. Treatment for calcium channel blocker poisoning: a systematic review. Clin Toxicol 2014, [Early Online: 1-19].
4. Masson R., Colas V., Parienti J.J., Lehoux P., Massetti M., Charbonneau P., et al. A comparison of survival with and without extracorporeal life support for severe poisoning due to drug intoxication. Resuscitation 2012, 83:1413-1417.
5. Daubin C., Lehoux P., Ivascau C., Tasle M., Bousta M., Lepage O., et al. Extracorporeal life support in severe drug intoxication: a retrospective cohort study of seventeen cases. Crit Care 2009, 13:R138.
6. Mégarbane B., Leprince P., Deye N., Résière D., Guerrier G., Rettab S., et al. Emergency feasibility in medical intensive care unit of extracorporeal life support for refractory cardiac arrest. Intensive Care Med 2007, 33:758-764.
7. Babatasi G., Massetti M., Verrier V., Lehoux P., Le Page O., Bruno P.G., et al. Intoxication sévère par médicaments cardiotoxiques: intérêt de l'assistance cardiocirculatoire percutanée en urgence. Arch Mal Coeur Vaiss 2001, 94:1386-1391.
8. Paden M.K., Conrad S.A., Rycus P.T., Thiagarajan R.R. Extracorporeal Life Support Organization Registry Report 2012. ASAIO J 2013, 59:202-210.
9. Thiagarajan R.R., Brogan T.V., Scheurer M.A., Laussen P.C., Rycus P.T., Bratton S.L. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 2009, 87:778-785.
10. Vats A., Pettignano R., Culler S., Wright J. Cost of extracorporeal life support in pediatric patients with acute respiratory failure. Crit Care Med 1998, 26:1587-1592.
11. Peek G.J., Mugford M., Tiruvoipati R., Wilson A., Allen E., Thalanany M.M., et al. CESAR trial collaboration. Efficacy and economic assessment of conventional ventilator support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicenter randomized controlled trial. Lancet 2009, 374:1351-1363.
12. Canadian Institutes of Health Research [consulted October 2013]. http://www.cihr-irsc.gc.ca/e/39033.html.
13. Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997, 16:33-64.
14. Baud F.J., Megarbane B., Deye N., Leprince P. Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit Care 2007, 11:207.
15. Statistics Canada [consulted October 2013]. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/health26-eng.htm.
16. Ministry of Health and Long Term Care Schedule of benefits for physician services under the Health Insurance Act (October 2013 version) 2013, 888.
17. Ministry of Health and Long Term Care of Ontario (MOHLTC) Ambulance services billing [consulted November 2013]. http://www.health.gov.on.ca/en/public/publications/ohip/amb.aspx.
18. Ministry of Health and Long Term Care of Ontario (MOHLTC) 2010 Annual Report of the Office of the Auditor General of Ontario, Chapter 3, section 3.05: Hospital ED 2011, 132-163.
19. St-Onge M., Archambault P., Lesage N., Guimont C., Poitras J., Blais R. Adherence to calcium channel blocker poisoning treatment recommendations in two Canadian cities. Clin Toxicol 2012, 50:424-430.
20. Sud S., Mittmann N., Cook D.J., Geerts W., Chan B., Dodek P., et al. Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med 2011, 184:1289-1298.
21. Cooke C.R., Kahn J.M., Watkins T.R., Hudson L.D., Rubenfeld G.D. Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 2009, 136:79-88.
22. Lone N.I., Seretny M., Wild S.H., Rowan K.M., Murray G.D., Walsh T.S. Surviving intensive care: a systematic review of healthcare resource use after hospital discharge. Crit Care Med 2013, 41:1832-1843.
23. Statistics Canada Median total income [consulted in April 2014]. http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/famil107c-eng.htm.
24. DeLange D.W., Sikma M.A., Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol 2013, 51:385-393.
25. Desebbe O., Rosamel P., Henaine R., Vergnat M., Farhat F., Dubien P.Y., et al. Transport interhospitalier sous extracorporeal life support: résultats et perspectives après cinq ans d'expérience. Ann Fr Anesth Reanim 2013, 32:225-230.
26. Briggs A.H., Weinstein M.D., Fenwick E.A., Karnon J., Sculpher M.J., Paltiel A.D. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making 2012, 32:722-732.
27. Shiroiwa T., Sung Y.-K., Fukuda T., Lang H.C., Bae S.C., Tsutani K. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?. Health Econ 2010, 19:422-437.
28. Schumacher R.E., Roloff D.W., Chapman R., Snedecor S., Bartlett R.H. Extracorporeal membrane oxygenation in term newborns. A prospective cost-benefit analysis. ASAIO 1993, J 3:873-879.
29. Peek G.J., Elbourne D., Mugford M., Tiruvoipati R., Wilson A., Allen E., et al. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracoporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess 2010, 14(35):1-46.
30. Roncon-Albuquerque R., Almeida V., Lopes M., Castro L., Pedrosa A., et al. Cost analysis of miniaturized ECMO in H1N1-related ARDS managed by a single caregiver. Intensive Care Med 2014, [April (Epub ahead of print)].
31. Freeman C.L., Bennett T.D., Casper T.C., Larsen G.Y., Hubbard A., Wilkes J., et al. Pediatric and neonatal extracorporeal membrane oxygenation: does center volume impact mortality?. Crit Care Med 2014, 42:512-519.
32. Cavarocchi N., Wallace S., Hong E., Tropea A., Byrne J., Pitcher H., et al. A cost-reducing extracorporeal membrane oxygenation (ECMO) program model: a single institution experience. Perfusion 2014, [May 13 (Epup ahead of print)].
33. Medical Advisory Secretariat of the Ministry of Health and Long-Term Care of Ontario Extracorporeal lung support technologies-bridge to recovery and bridge to lung transplantation in adult patients, an evidence-based analysis. Ont Health Technol Assess Ser 2010, 10:37-38.
34. Wang S.M., Chou Y.C., Yeh M.Y., Chen C.H., Tzeng W.C. Factors associated with quality of life after attempted suicide: a cross-sectional study. J Clin Nurs 2013, 22(15-16):2150-2159.
35. Brown G.K., Ten Have T., Henriques G.R., Xie S.X., Hollander J.E., Beck A.T. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA 2005, 294(5):563-570.